Mary L Flores, CDPT | |
120 S 3rd St, Yakima, WA 98901-2875 | |
(509) 248-1800 | |
Not Available |
Full Name | Mary L Flores |
---|---|
Gender | Female |
Speciality | Counselor - Addiction (substance Use Disorder) |
Location | 120 S 3rd St, Yakima, Washington |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1578754917 | NPI | - | NPPES |
00053198 | Other | WA | REGISTERED COUNSELOR |
Mailing Address | Practice Location Address |
---|---|
Mary L Flores, CDPT 402 N 4th St, Suite 300, Yakima, WA 98901-2470 Ph: (509) 453-9387 | Mary L Flores, CDPT 120 S 3rd St, Yakima, WA 98901-2875 Ph: (509) 248-1800 |
News Archive
Mindray Medical International Limited, a leading developer, manufacturer and marketer of medical devices worldwide, today announced that it will showcase the latest enhancements to the DC-8 ultrasound system at the 98th Annual Meeting of the Radiological Society of North America to be held during November 25-30, 2012 in Chicago.
Blue light can both set the mood and set in motion important biological responses. Researchers at the University of Pennsylvania's School of Medicine and School of Arts and Sciences have teased apart the separate biological responses of the human eye to blue light, revealing an unexpected contest for control.
PLC Systems Inc. (OTC Bulletin Board: PLCSF), a company focused on innovative cardiac and vascular medical device-based technologies, today announced that it will demonstrate its RenalGuard System(TM) at Transcatheter Cardiovascular Therapeutics (TCT) 2009, sponsored by the Cardiovascular Research Foundation, September 21 - 25, 2009, in San Francisco, California. More than 11,000 clinicians and professionals are expected to attend this event.
This week Nature Nanotechnology journal (October 12th) reveals how scientists from the London Centre for Nanotechnology (LCN) at University College London are using a novel nanomechanical approach to investigate the workings of vancomycin, one of the few antibiotics that can be used to combat increasingly resistant infections such as methicillin-resistant Staphylococcus aureus (MRSA).
In many countries, genome sequencing technology is now starting to become available in the clinic, where it helps to diagnose rare Mendelian diseases and contributes to personalized cancer therapy. The analysis of personal genomes also creates unprecedented opportunities for predictive health counseling, ancestry research, and many more applications that are just starting to emerge.
› Verified 5 days ago